Quantitative structure-activity relationships (QSARs) in the European REACH system: Could these approaches be applied to nanomaterials?

Practical Aspects of Computational Chemistry: Methods, Concepts and Applications

Volumn , Issue , 2010, Pages 201-216

  Puzyn, Tomasz ^a,b   Leszczynska, Danuta ^a,c   Leszczynski, Jerzy ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GDA SK   (Poland)

^c Jackson State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890195022     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-90-481-2687-3_9     Document Type: Chapter

References (74)

1. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, and amemding Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC, Official Journal of the European Union, L 396/1; The European Parliament and the Council of the European Union, Brussels, 2006
2. Guidance on registration, Guidance for the implementation of REACH; European Chemicals Agency, Helskinki, 2008
3. T.W. Schultz et al., Quantitative structure-activity relationships (QSARS) in toxicology: A historical perspective. THEOCHEM 622, 1-22 (2003)
4. T.W. Schultz et al., The present status of QSAR in toxicology. THEOCHEM 622, 23-38 (2003)
5. R. Todeschini et al., Handbook of Molecular Descriptors (Wiley-VCH, Weinheim, 2000)
6. F. Jensen, Introduction to Computational Chemistry (Wiley, Chichester, 1999)
7. G.B. Rocha et al., RM1: A reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I, J. Comput. Chem. 27, 1101-1111 (2006)
8. J.J.P. Stewart, Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. J. Mol. Model. 13, 1173-1213 (2007)
9. T. Puzyn et al., Calculation of quantum-mechanical descriptors for QSPR at the DFT level: Is it necessary? J. Chem. Inf. Model. 48, 1174-1180 (2008)
10. T.I. Opera et al., 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results. Drug Des. Discov. 12, 29-51 (1994)
11. M. Ravi et al., 4D-QSAR analysis of a set of ecdysteroids and a comparison to CoMFA modeling. J. Chem. Inf. Comput. Sci. 41, 1587-1604 (2001)
12. O. Mekenyan et al., In silico modelling of hazard endpoints: Current problems and perspectives. SAR QSAR Environ. Res. 14, 361-371 (2003)
13. V.E. Kuz'min et al., Hierarchic system of QSAR models (1D-4D) on the base of simplex representation of molecular structure. J. Mol. Model. 11, 457-467 (2005)
14. M.T.D. Cronin et al., Pitfalls in QSAR. THEOCHEM 622, 39-51 (2003)
15. Guidance Document on the Validation of (Quantitative) Structure Activity Relationship [(Q) SAR] Models No. 69; OECD Series on Testing and Assessment; Organisation of Economic Cooperation and Development: Paris, France 2007. http://www.oecd.org. Accessed May 2008
16. P. Gramatica, Principles of QSAR models validation: Internal and external. QSAR Comb. Sci. 26, 694-670 (2007)
17. JRC, European Chemicals Bureau, Computational Toxicology Group. http://ecb.jrc.it/qsar/. Accessed May 2008
18. L. Eriksson et al., Methods for reliability and uncertainty assessment and applicability evaluations of classification-and regression-based QSARs. Environ. Health Perspect. 111, 1361-1375 (2003)
19. T.I. Netzeva et al., Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships-The report and recommendations of ECVAM Workshop 52. Altern. Lab. Anim. 33, 155-173 (2005)
20. A. Golbraikh et al., Beware of q2!. J. Mol. Graph. Model. 20, 269-276 (2002)
21. T. Puzyn et al., How do the partitioning properties of polyhalogenated POPs change when chlorine is replaced with bromine? Environ. Sci. Technol. 42, 5189-5195 (2008)
22. K. Thomas et al., Research strategies for safety evaluation of nanomaterials, Part VIII: International efforts to develop risk-based safety evaluations for nanomaterials. Toxicol. Sci. 92, 23-32 (2006)
23. Market outlook for nanomaterials for electronics applications: Semiconductors, solar displays, sensors, RFID, Lighting The Information Network: New Tripoli, PA, 2008. http://www. theinformationnet.com
24. K.J. Klabunde, Introduction to Nanotechnology, in Nanoscale Materials in Chemistry, ed. by K.J. Klabunde (Wiley Interscience, New York, 2001)
25. A.G. Mamalis, Recent advances in nanotechnology. J. Mater. Process. Technol. 181, 52-58 (2007)
26. P.J. Borm et al., The potential risks of nanomaterials: A review carried out for ECETOC. Part. Fibre Toxicol. 3, 11 (2006)
27. M.R. Wiesner et al., Assessing the risks of manufactured nanomaterials. Environ. Sci. Technol. 40, 4336-4345 (2006)
28. S. Zuin et al., Effect-Oriented Physicochemical Characterization of Nanomaterials, in Nano-notoxicology: Characterization, Dosing and Health Effects, ed. by N.A. Monteiro-Riviere, C.L. Tran (Informa Healthcare USA, New York, 2007)
29. D.Y. Lyon et al., Bacterial cell association and antimicrobial activity of a C-60 water suspension. Environ. Toxicol. Chem. 24, 2757-2762 (2005)
30. C.M. Sayes et al., The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 4, 1881-1887 (2004)
31. A. Magrez et al., Cellular toxicity of carbon-based nanomaterials. Nano Lett. 6, 1121-1125 (2006)
32. F.R. Tian et al., Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol. In Vitro 20, 1202-1212 (2006)
33. T. Gordon et al., Pulmonary effects of inhaled zinc-oxide in human-subjects, guinea-pigs, rats, and rabbits. Am. Ind. Hyg. Assoc. J. 53, 503-509 (1992)
34. B. Rehn et al., Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: Untreated and surface treated. Toxicol. Appl. Pharmacol. 189, 84-95 (2003)
35. Y. Chen et al., Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats. Toxicol. Ind. Health 20, 21-27 (2004)
36. Towards a European strategy for nanomaterials, COM(2004) 338; European Commission: Brussels, 2004
37. Nanosciences and nanotechnologies: An action plan for Europe 2005-2009, COM(2005) 243; European Commission, Brussels, 2005
38. Communication from the Commission to the European Parliament, The Council and the European Economic and Social Committee: Regulatory aspects of nanomaterials, SEC (2008) 2036; Commision of the European Communities, Brussel, 2008
39. ETUC Resolution on nanotechnologies and nanomaterials, European Trade Union Confederation, Brussels, 2008
40. The appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials, European Commision, Scientific Committee on Emerging and Newly-Identified Health Risks, Brussels, 2007
41. I.P. Suzdalev, Size effects and intercluster interactions in nanosystems. Zh. Obshch. Khim 72, 611-616 (2002)
42. V.Y. Shevchenko et al., The structural diversity of the nanoworld. Glass Phys. Chem. 29, 577-582 (2003)
43. A.D. Maynard et al., Assessing exposure to airborne nanomaterials: Current abilities and future requirements. Nanotoxicology 1, 26-41 (2007)
44. A. Worth, Computational nanotoxicology-towards a structure-activity based paradigm for investigationg the activity of nanoparticles. In Icon Workshop. Towards Predicting Nano-Bio Interactions, Zurich, Switzerland, 2007
45. G. Oberdörster et al., for ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part. Fibre Toxicol. 2, 8, (2005)
46. M.A. Poggi et al., Scanning probe microscopy. Anal. Chem. 76, 3429-3443 (2004)
47. M.K. Shukla et al., A density functional theory study on the effect of shape and size on the ionization potential and electron affinity of different carbon nanostructures. Chem. Phys. Lett. 428, 317-320 (2006)
48. +[N, P, As, Sb]. Int. J. Quantum Chem. 105, 429-436 (2005)
49. n with n = 1-9. J. Phys. Chem. B 110, 8998-9007 (2006)
50. 2)n~ (n = 1-10) using photoelectron spectroscopy. J. Am. Chem. Soc. 129, 3022-3026 (2007)
51. L.M. Kukreja et al., Variable band gap ZnO nanostructures grown by pulsed laser deposition. J. Cryst. Growth 268, 531-535 (2004)
52. J.L. Faulon et al., The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 43, 707-720 (2003)
53. J.L. Faulon et al., The signature molecular descriptor. 2. Enumerating molecules from their extended valence sequences. J. Chem. Inf. Comput. Sci. 43, 721-734 (2003)
54. C.J. Churchwell et al., The signature molecular descriptor. 3. Inverse-quantitative structure-activity relationship of ICAM-1 inhibitory peptides. J. Mol. Graph. Model. 22, 263-273 (2004)
55. J.L. Faulon et al., The signature molecular descriptor. 4. Canonizing molecules using extended valence sequences. J. Chem. Inf. Comput. Sci. 44, 427-436 (2004)
56. I. Gutman et al., The graph of atomic orbitals and its basic properties. 1. Wiener index. MATCH Commun. Math. Comput. Chem. 53, 215-224 (2005)
57. I. Gutman et al., The graph of atomic orbitals and its basic properties. 2. Zagreb indices. MATCH Commun. Math. Comput. Chem. 53, 225-230 (2005)
58. A.P. Toropova et al., QSPR modeling mineral crystal lattice energy by optimal descriptors of the graph of atomic orbitals. Chem. Phys. Lett. 428, 183-186 (2006)
59. A.A. Toropov et al., An application of graphs of atomic orbitals for QSAR modeling the toxicity of metal oxides. Chemosphere, 2009 (submitted)
60. A. Helland et al., Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ. Health Perspect. 115, 1125-1131 (2007)
61. K. Donaldson et al., Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 92, 5-22 (2006)
62. K. Donaldson et al., Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2, 10 (2005)
63. R. Hardman, A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 114, 165-172 (2006)
64. T.J. Brunner et al., In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40, 4374-4381 (2006)
65. L.K. Limbach et al., Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 39, 9370-9376 (2005)
66. A.A. Toropov et al., Predicting water solubility and octanol water partition coefficient for carbon nanotubes based on the chiral vector. Comput. Biol. Chem. 31, 127-128 (2007)
67. A.A. Toropov et al., A new approach to the characterization of nanomaterials: Predicting Young's modulus by correlation weighting of nanomaterials codes. Chem. Phys. Lett. 433, 125-129 (2007)
68. D. Martin et al., QSPR modeling of solubility of polyaromatic hydrocarbons and fullerene in 1-octanol and n-heptane. J. Phys. Chem. B 111, 9853-9857 (2007)
69. A.R. Katritzky et al., CODESSA PRO. COmprehensive DEscriptors for Structural and Statistical Analysis, University of Florida, USA, 2001-2005. http://www.codessa-pro.com. Accessed June 2007
70. H. Liu et al., Accurate quantitative structure-property relationship model to predict the solubility of C60 in various solvents based on a novel approach using a least-squares support vector machine. J. Phys. Chem. B 109, 20565-20571 (2005)
71. 60) in organic solvents. J. Chem. Inf. Comput. Sci. 41, 1067-1074 (2001)
72. 60 in organic solvents using optimal descriptors calculated with SMILES. Chem. Phys. Lett. 441, 119-122 (2007)
73. 60 solubility in organic solvents: The use of quantum-chemical and topological descriptors in QSPR study. J. Nanopart. Res., 2009 (submitted)
74. A.A. Toropov et al., QSAR modeling toxicity of nanosized oxides towards E. coli bacteria using the SMILES-based optimal descriptors. Chem. Biol. Drug Des., 2009 (submitted)